Qualigen extends its line of generic Diazepam with two new presentations
The only generic Diazepam with four presentations on the Spanish market
Qualigen extends its Diazepam line with the launch of two new presentations, Diazepam Qualigen EFG 5 mg in packages of 40 tablets and 10 mg in packages of 25 tablets.
Diazepam Qualigen EFG is the only Diazepam on the Spanish market with the acronym EFG, which identifies the generic drugs in Spain, based on the mandatory bioequivalence studies to the original Valium®.
Diazepam Qualigen EFG was launched into the market in June 2016 with two presentations of 30 tablets, 5 mg and 10 mg. This extended line of Diazepam Qualigen EFG with two new formats contributes to consolidate the extensive product portfolio of Qualigen’s singular generics, in this case with a drug for disorders of the central nervous system.
Diazepam is indicated for the treatment of anxiety disorders besides being prescribed as a muscle relaxant and as an anticonvulsant too.
Diazepam Qualigen EFG requires a prescription for dispensing it and is financed by the Spanish National Health System.
With these two new launches, Qualigen strengthens its position as a laboratory with a large product portfolio of drugs for disorders related to the central nervous system: antidepressants, antipsychotics, antiepileptics, antiparkinsonians, anxiolytics, hypnotics and for the treatment of Alzheimer...